FDC Limited, one of the leading drug makers in the country, has informed that the company has received the US Food and Drug Administration approval for its Timolol Maleate eye solution.

Timolol Maleate Ophthalmic Solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

Mumbai-headquartered FDC Limited operates as a pharmaceutical company primarily in India. Its products include formulations and active pharmaceutical ingredients (APIs). The company exports its products to approximately 50 countries, including the United States, South Africa, United Kingdom, Europe, and Japan.

Shares of the company slipped Rs 0.55, or 2%, to end at Rs 29.60. The total volume of shares traded was 56,773 at the BSE. Stock Markets ended flat today. The trading session was range-bound and volumes were low.